SA

Steven W. Andrews

AB Array Biopharma: 64 patents #4 of 335Top 2%
AB AbbVie: 22 patents #82 of 1,308Top 7%
IN Intermune: 6 patents #12 of 57Top 25%
LO Loxo Oncology: 6 patents #8 of 31Top 30%
EL Eli Lilly: 5 patents #670 of 2,858Top 25%
JT Japan Tobacco: 1 patents #582 of 1,187Top 50%
📍 Boulder, CO: #13 of 5,018 inventorsTop 1%
🗺 Colorado: #94 of 40,980 inventorsTop 1%
Overall (All Time): #15,441 of 4,157,543Top 1%
97
Patents All Time

Issued Patents All Time

Showing 76–97 of 97 patents

Patent #TitleCo-InventorsDate
7491794 Macrocyclic compounds as inhibitors of viral replication Lawrence M. Blatt, Kevin Ronald Condroski, Yutong Jiang, April L. Kennedy, Peter J. Stengel +1 more 2009-02-17
7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster, Edward Wang, Thomas C. Malone 2008-08-19
7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster 2008-07-01
7351825 Cyclopropane compounds and pharmaceutical use thereof Takashi Inaba, Julia Haas, Makoto Shiozaki, Nicole M. Littmann, Katsutaka Yasue +9 more 2008-04-01
7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster, Clarence Eugene Hull, III 2006-08-29
7060844 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Xialing Guo, Zhen Zhu, Clarence Eugene Hull, III, Julie A. Wurster, Shimiao Wang +2 more 2006-06-13
7015220 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster, Edward Wang, Thomas C. Malone 2006-03-21
7005444 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster 2006-02-28
6765012 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster, Edward Wang, Thomas C. Malone 2004-07-20
6747025 Kinase inhibitors for the treatment of disease Michael E. Garst, Xialing Guo, Jonathan J. Hebert, Thomas C. Malone, Julie A. Wurster +1 more 2004-06-08
6699863 Kinase inhibitors for the treatment of disease Jonathan J. Hebert 2004-03-02
6559173 3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster 2003-05-06
6541504 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors Julie A. Wurster, Clarence Eugene Hull, III, Edward Wang, Thomas C. Malone, Xialing Guo +1 more 2003-04-01
6403649 Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents David F. Woodward, Robert M. Burk, Michael E. Garst 2002-06-11
6395787 Ocular hypotensive lipids David F. Woodward, Helen Usansky, Robert M. Burk, June Chen, Achim H. Krauss +1 more 2002-05-28
6258844 Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents Michael E. Garst, Michael B. Roof, Ming Fai Chan, David F. Woodward, Robert M. Burk +1 more 2001-07-10
5688819 Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents David F. Woodward, Robert M. Burk, Michael E. Garst 1997-11-18
5607978 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents David F. Woodward, Robert M. Burk, Michael E. Garst 1997-03-04
5486540 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents 1996-01-23
5457131 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents 1995-10-10
5387608 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents 1995-02-07
5352708 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents David F. Woodward, Robert M. Burk, Michael E. Garst 1994-10-04